In honor of Black History Month, I spoke with six Black women founders about how they’ve transformed resistance into ...

Blueprint Medicines Corporation, a Delaware-based biopharmaceutical company, recently released its financial results for the year ended December 31, 2024, along with key business highlights. The ...

Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Hormone hazards can hide in everything from cosmetics to cleaning products. Here's how to avoid endocrine disruptors!

Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.

In an era where software development costs continue to rise, organizations can't afford the luxury of building first and ...

The showdown between House and Senate Republicans is escalating as the two groups barrel ahead with their contrasting ...

This concealer is the best I've tried so far. My skin is textured and tends to be dry in the colder months, so I appreciate ...

The blueprint for app development successDiscover the four foundational pillars to creating mobile apps that stand out and deliver impact. By Lloyd Hendricks, Practice head of mobile services, ...